MedTrace Logo

Mifepristone and Misoprostol Versus Misoprostol Alone for Missed Abortion: A Randomized-controlled Trial

NCT02342002 · Status: TERMINATED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 416

Last updated 2019-01-15

No results posted yet for this study

Summary

The purpose of the proposed study is to compare - in a randomized, placebo-controlled, double-blinded trial - a combination of mifepristone and misoprostol to misoprostol used alone for missed abortion.

Conditions

  • Missed Abortion
  • Pregnancy

Interventions

DRUG

Mifepristone

Mifepristone for treatment of missed abortion

DRUG

Misoprostol

Misoprostol for treatment of missed abortion

Sponsors & Collaborators

  • Gynuity Health Projects

    lead OTHER

Principal Investigators

  • Hillary Bracken, PhD · Gynuity Health Projects

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
49 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-01-31
Primary Completion
2018-12-31
Completion
2018-12-31

Countries

  • Argentina
  • Gabon
  • Mexico
  • Pakistan

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02342002 on ClinicalTrials.gov